drugset / Trial / NCT05580250
A Study of LY3526318 in Healthy Male Japanese Participants
RandomizedSequentialDouble-blindBasic science
Summary
This is a study of LY3526318 in healthy male Japanese. The main purposes of this study are to: * Assess how safe and well tolerated LY3526318 is when given by mouth. * Measure how LY3526318 affects the kidney and the liver. The study will be conducted in three parts (Part A, Part B, Part C). Participants may only enroll in one part. After screening, the study will last from one to two weeks, depending on part.
Timeline
- Start
- 2022-11-22
- Primary completion
- 2022-12-08
- Completion
- 2022-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3526318 | Unknown | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Simvastatin | Small molecule | — | Oral |
| Background | Iohexol | Diagnostic / imaging agent | — | Intravenous |
Indications
No indication recorded.